Lateral Lymph Node Dissection for Rectal Carcinoma



Lateral Lymph Node Dissection for Rectal Carcinoma


Petr V. Tsarkov

Inna Tulina



INTRODUCTION/OBJECTIVES

Recent progress in rectal cancer staging, development of surgical procedures including total mesorectal excision (TME) and nerve-sparing TME, and advances in neo- and adjuvant therapy (such as chemotherapy and radiotherapy [RT]) have dramatically reduced locoregional recurrence, but unfortunately still have not eliminated it. Local recurrences are likely to be the result of one of the following reasons—missed microscopic involvement of circular resection margin, rare involvement of distal mesorectum beyond the “5-cm” barrier, lateral spread to pelvic lymph nodes beyond the mesorectum, and possibly seeding of the pelvis during surgical dissection.

Early anatomic study by Gerota in 1895 initially described the presence of lateral lymphatic flow in the rectum. In 1925 Villemin and later in 1950 Blair et al. using dye injection described lymphatic pathways in the pelvis. They suggested that lymphatic drainage from the rectum follows three main routes: the upper route is along the superior rectal artery, the middle route is along the middle rectal arteries and goes to the obturator spaces, and the lower route is along the inferior rectal arteries leading to the iliac basins. The lymphatic drainage to the lateral compartment was suggested to have an important role for low rectal cancers located at or below peritoneal reflection. The clear connection between the lymphatics of the mesorectum below peritoneal reflection and lateral pelvic spaces was also recently demonstrated.

Biological behavior of primary rectal cancer is characterized by relatively slow growth and being localized for a long time compared to other gastrointestinal malignancies. This behavior determines the concept of extended lymph node dissection. Lymph node metastases first occur along the well-described lymphatic channels and follow a well-defined pattern. Lateral lymphatics in the pelvis consist of channels from pelvic organs such as bladder, genital organs, and rectum. Lymphatic spread from anteriorly located organs goes to the more proximal part of internal iliac vessels, whereas lateral lymphatics of the rectum drain into the distal part of internal iliac vessels close to the root of the internal pudendal artery. Lymphatic vessels that extend laterally from the rectum are relatively small, but it does not reduce their importance in the lymphatic spread in rectal cancer. When reviewing series of patients who developed local recurrence after radical TME, lateral pelvic wall involvement is found in 20-80% of them. Thus, lateral lymph nodes (LLNs) can be a potential site of locoregional recurrence even in the absence of circumferential margin involvement.

According to Japanese concepts based on early anatomic studies of Senba and Kuru, the rectal muscle tube is surrounded by three fat-tissue “spaces.” The first space corresponds to the mesorectum that is enveloped by rectal fascia propria. Two hypogastric nerves (HNs) and the pelvic plexuses (PPs) are attached to both posterolateral sides of the mesorectum. Adjacent to the nerves lie the right and left second fat-tissue spaces. Lateral borders are the internal iliac vessels and their visceral branches. The left and right third spaces are located lateral to the internal iliac vessels in both obturator fossae. Since being established as a standard in Japanese colorectal surgery, this three-space dissection around the rectum is considered essential to achieve complete pelvic lymph node dissection in all three areas.

The Japanese system of grading lymph node involvement is different from the tumor, node and metastasis system and is based on the metastatic lymph node location in the abovementioned spaces and the distance from the primary tumor rather than on the total number of involved lymph nodes. According to the Japanese classification of rectal cancer, N1 (pararectal) lymph nodes are located
inside the mesorectal fascia envelope up to the origin of the superior rectal artery. The mesorectal fascia represents a distinct anatomic barrier toward direct cancer spread to extramesorectal lymphatics, and thus the major route for lymphatic spread is upward along the superior rectal artery. Upward N2 (intermediate) lymph nodes lie within the vascular pedicle between the last sigmoid artery (SA) and left colic artery (LCA). Lateral N2 lymph nodes are located outside the mesorectal fascia between HN and PP and internal iliac arteries (IIAs) and their branches. N3 (main or apical) lymph nodes in the upward direction are found around the trunk of the inferior mesenteric artery (IMA) above the origin of the LCA. The N3 lymph nodes in the lateral direction are located along the common iliac vessels and in the obturator space. Subsequent classification of lymph node dissection in rectal cancer is based on the grades of removed lymph nodes. Thus, D1 lymph node dissection is aimed at removing N1 lymph nodes, D2 lymph node dissection encompasses N2 lymph nodes, and D3 lymph node dissection—N3 lymph nodes. In this way, TME can be represented as a D1/D2 lymph node dissection based on the level of upward lymphatic resection, and D3 lymph node dissection involves resection of lymph nodes around the IMA trunk and internal iliac and obturator lymph nodes, which is often called the extended aortopelvic lymph node dissection or lateral pelvic lymph node dissection or lateral lymph node dissection (LLD).

Unlike the Eastern world, D3 lymph node dissection for rectal cancer is uncommon in Western countries because of the belief in the negligible incidence of LLN involvement and the possibility of RT to prevent and cure LLN metastases. In Eastern series, the rate of pathologically proven metastatic mesorectal and lateral pelvic lymph nodes in low rectal cancer patients may be as high as 39% even after the completion of neoadjuvant RT. The Japanese Society for Cancer of the Colon and Rectum has presented the data from the Japanese registry, which showed that among 2,916 patients with rectal cancer, LLN involvement was present in 20.1% of patients who underwent prophylactic LLD because of low location of the tumor (below the peritoneal reflection) and/or cancer invasion through the muscularis propria. Among the patients who had involved mesorectal lymph nodes, the incidence of LLN involvement was 27%. In the review of neoadjuvant chemoradiotherapy (CRT) and TME surgical treatment of 366 patients with rectal cancer, Kim et al. have reported that LLN metastasis is the major cause of locoregional recurrence.

The Western data on the incidence of LLN involvement and lateral pelvic recurrence is scarce. Recent data from Oxford, United Kingdom, suggest that in low rectal cancer, magnetic resonance imaging (MRI) can identify enlarged lymph nodes in lateral pelvic compartments in 85% of patients and LLNs with malignant features were found in 10% of patients. All of these patients underwent TME and 69% had preoperative CRT; the overall 5-year local recurrence rate was 18.7% and 5-year lateral LLR was 11.8%. Our group performed a single-center randomized controlled trial that compared patients with very low rectal cancer (below 3 cm) who underwent standard abdominoperineal excision (APE) with patients who underwent APE combined with prophylactic LLD. This study demonstrated that the incidence of local recurrence was significantly lower with LLD than with only APE—13.8% versus 20.7%, respectively.

Despite all modern trends of neoadjuvant CRT and TME, locoregional recurrence attests to the need for more intense surgical research and/or technical improvements.




PREOPERATIVE PLANNING

Preoperative planning includes a thorough physical examination. Enlarged inguinal lymph nodes should be noted. Physical examination, including digital rectal examination, vaginal inspection, and regional lymph node assessment, may help assess the possible risk of LLN involvement. Rigid proctoscopy is performed to assess the accurate distance from the lower border of the tumor to the anal verge and/or dentate line. Colonoscopy is required to identify any synchronous lesions. However, barium or Gastrografin enema is helpful in cases with severe tumor stenosis. Although some authors do not suggest chest CT as a routine diagnostic tool, all of our patients undergo chest CT to exclude pulmonary metastasis. A routine examination list includes an abdominal ultrasound (US) or an abdominal CT scan with intravenous contrast. In patients with nonobstructing cancer, a rectal US is performed to stage the lesion. A phased-array MRI obtained by a colorectal-surgery-oriented radiologist is a vital part of the multidisciplinary approach to the treatment. MRI identification of mesorectal and LLN >5 mm with irregular borders, mixed magnetic resonance signal intensity, or both is considered as highly suspicious for tumor involvement. LLN location, number, and their relation to any neighboring anatomic structures should be clearly noted.


SURGICAL TECHNIQUE—OPEN LATERAL LYMPH NODE DISSECTION


Positioning

The patient is positioned in the modified Lloyd-Davies position. Safe positioning of the patient’s bony prominent part is very important; padding of neurovascular bundles is performed to prevent damage. The surgeon is initially positioned on the left side of the patient, the first assistant is positioned on the right side, and the second assistant is positioned between the patient’s legs. During surgery, the surgeon can change sides several times as needed. After induction of anesthesia, an additional digital rectal examination is performed to verify the tumor location, height, mobility, and the involvement of any other organs.


Laparotomy and Exposure

A laparotomy is performed through a lower midline incision; great care is taken not to damage the bladder, which is usually dissected and retracted to the left because the 2 cm above pubic bone is quite important to optimize adequate visualization of the lower pelvis. After the midline laparotomy and intra-abdominal inspection, a wound retracting system is installed. The surgeon retracts the small bowel, right colon, omentum, and proximal left colon under the blades of the retractor to open the sigmoid colon and its mesentery. The optimal view should include the duodenum as an upper border, aorta and vena cava on the right side with the white line of Toldt on the left side.



Open Para-aortic D3 Lymph Node Dissection

We perform routine para-aortic lymphadenectomy for T3/4 rectal, sigmoid, and left colon cancers with the suspicious lymph nodes on preoperative diagnosis. The vascular pedicle containing IMA and fat tissue around it is approached in a lateral-to-medial direction. The sigmoid colon is lifted up and the avascular space behind it is entered. Applying traction and countertraction the posterior surface of the sigmoid mesocolon is released gently from the underlying Toldt’s and prerenal fascia, left ureter, gonadal vessels, and hypogastric plexus and nerve. The root of the IMA is reached from behind and peritoneum incision is made medial to the root of the IMA to connect the planes. The surgeon inserts the left index finger through the medial peritoneal incision and lifts up the IMA root with a hook, thus protecting underlying preaortic nerve plexus and other vital structures from injury while dissecting at the IMA root. The medial peritoneal incision is extended up to the duodenum and curved to follow the duodenum lower border. The latter is gently retracted cranially and carefully dissected. Next, the preaortic fascia is opened and fat tissue surrounding the IMA root is cleared off between the left and right splanchnic lumbar nerves leaving the latter intact. It is preferable to use Harmonic scalpel (Ethicon Endo-Surgery, Inc., Cincinnati, OH) to reduce nerve damage at this step. The preaortic fat and the fat around the root of IMA that contains apical lymph nodes is cleared off the aorta and the IMA surface and dissected downward. Using scissors or Harmonic scalpel the IMA is freed circumferentially from the paravasal fat all way down to the origin of the LCA, sigmoid arteries (SAs), and superior rectal arteries (Fig. 41-1). The mobilized preaortic and paravasal fat is posteriorly retraced. This method of vessel “skeletizing” enables performing extended para-aortic lymph node dissection together with precise isolation and separate dissection of IMA branches without excessive colon resection. To perform D3 lymph node dissection in upward direction, the space between the IMA and LCA should be cleared out and the fat with apical lymph nodes removed. The IMA can be divided either at the root or below the LCA depending on the length of the sigmoid colon and the possibility of using it for colorectal anastomosis. The inferior mesenteric vein is divided at the same level as IMA. Any type of vessel ligation technique can be used, including advanced bipolar device or an ultrasonic scalpel with advanced hemostasis technology.

Further mobilization of the sigmoid colon, colon division, and rectal mobilization fully correspond to the principles of nerve-sparing TME described in several other chapters.


Open D3 Lateral Lymph Node Dissection

LLD can be performed either en bloc with the mesorectum if there is direct tumor invasion outside mesorectal fascia or as a separate maneuver after the rectum has been removed. The concept of LLD is removing of fatty and connective tissue outside the PP, around the internal iliac and common iliac vessels, and in the obturator cavity. The results of nerve-preserving LLD are the skeletonized iliac vessels and their branches, and preservation of obturator nerve (ON) and pelvic autonomic nerves (ON and PP).

The lateral pelvic area is classified into four regions: common iliac (N2 lymph nodes), internal iliac (N2 lymph nodes—“second” space), obturator (N3 lymph nodes—third space), and external iliac, according to the Japanese classification. The common iliac lymph nodes are rarely dissected because
the frequency of metastasis in this area is low. Before the start of LLD, the ureter and gonadal vessels from the corresponding side of the pelvis are medially retracted and fixed with vessel loop to achieve good exposure. The following structures are the anatomic landmarks for LLD:






FIGURE 41-1 Para-aortic lymph node dissection. A. Skeletonized IMA; B. Division of IMA. a, aorta; b, IMA; c, IMV; d, LCA; e, sigmoid arteries; f, superior rectal artery. IMA, inferior mesenteric artery; inferior mesenteric vein; LCA, left colic artery.



  • Lateral border—external iliac artery


  • Medial border—PP


  • Cranial border—bifurcation of common iliac artery


  • Caudal border—levator ani muscles and Alcock (pudendal) canal


  • Dorsal border— sciatic nerve






FIGURE 41-2 Right-side lateral lymph node dissection (LLD) with external iliac artery retracted medially. Peritoneal incision along external iliac artery. a, right ureter; b, right external iliac artery.

Three ways to enter and clear the obturator (third) space can be used.

The first approach is medial-to-lateral along the internal iliac vessels. The second method is paravesical, and the third technique is the lateral-to-medial approach that was developed by our group. We feel that this approach allows better visualization and manipulation in the obturator space. The surgeon stands on the side opposite to that of the dissection. The paravesical space is entered and the peritoneal dissection is extended to the external iliac vessels. The peritoneum across the external iliac artery is opened, the underlying vessels are freed (Fig. 41-2), and gently retracted medially with a vessel loop. Medial retraction of the iliac vessels helps access the caudal part of the obturator fossa, which is reached with difficulty by a conventional approach. The fat tissue is removed from the middle part of the obturator fossa between the external iliac vessels medially and psoas muscle laterally (Fig. 41-3). The external iliac vessels are pulled back to the lateral side of the obturator fossa and the fat removal is completed.

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

May 5, 2019 | Posted by in GENERAL | Comments Off on Lateral Lymph Node Dissection for Rectal Carcinoma

Full access? Get Clinical Tree

Get Clinical Tree app for offline access